Elite Pharmaceuticals Inc ELTP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ELTP is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.19
- Day Range
- $0.19–0.19
- 52-Week Range
- $0.04–0.21
- Bid/Ask
- $0.18 / $0.19
- Market Cap
- $205.64 Mil
- Volume/Avg
- 387,558 / 628,269
Key Statistics
- Price/Earnings (Normalized)
- 9.40
- Price/Sales
- 3.48
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Elite Pharmaceuticals Inc is a pharmaceutical company. It is principally engaged in the development and manufacture of oral, controlled-release products, using proprietary know-how and technology. The company's operating segment includes Abbreviated New Drug Applications (ANDA) and New Drug Applications (NDA). It generates maximum revenue from the ANDA segment. The company focuses on developing pain management products; manufacturing a line of generic pharmaceutical products with approved Abbreviated New Drug Applications; developing additional generic pharmaceutical products; development of other products in its pipeline including the products with its partners; and commercialization of new products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 53
- Website
- https://www.elitepharma.com
Valuation
|
Metric
|
ELTP
|
|---|---|
Price/Earnings (Normalized) | 9.40 |
Price/Book Value | 3.57 |
Price/Sales | 3.48 |
Price/Cash Flow | 22.91 |
Price/Earnings
ELTP
Financial Strength
|
Metric
|
ELTP
|
|---|---|
Quick Ratio | 2.04 |
Current Ratio | 3.07 |
Interest Coverage | 1.75 |
Quick Ratio
ELTP
Profitability
|
Metric
|
ELTP
|
|---|---|
Return on Assets (Normalized) | 47.41% |
Return on Equity (Normalized) | 72.07% |
Return on Invested Capital (Normalized) | 61.61% |
Return on Assets
ELTP
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Lwvlwrlqh | Pyj | $82.1 Bil | |||
| Merck KGaA ADR
MKKGY
| Mxtndpvj | Qnpbpq | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Vlcptthm | Fyf | $41.4 Bil | |||
| Viatris Inc
VTRS
| Yctmpswg | Hbxl | $14.4 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Vppjgbsr | Lwbj | $13.7 Bil | |||
| Catalent Inc
CTLT
| Gjnkrcjkc | Kylzlfd | $10.6 Bil | |||
| Perrigo Co PLC
PRGO
| Kxlwvqjcf | Jfx | $3.8 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Nbvljmn | Shljyw | $3.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Dtysmfz | Sbqf | $3.0 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Qlzlxtrbc | Lkvfq | $2.7 Bil |